Literature DB >> 8681805

Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene.

H Uyttendaele1, G Marazzi, G Wu, Q Yan, D Sassoon, J Kitajewski.   

Abstract

The int-3 oncogene was identified as a frequent target in Mouse Mammary Tumor Virus (MMTV)-induced mammary carcinomas and encodes the intracellular domain of a novel mouse Notch gene. To investigate the role of the int-3 proto-oncogene in mouse development and carcinogenesis, we isolated cDNA clones corresponding to the entire coding potential of the int-3 proto-oncogene. We propose to name this gene Notch4 and reserve the int-3 nomenclature for references to the oncogenic form. The deduced amino acid sequence of Notch4 contains conserved motifs found in Notch proteins; however Notch4 has fewer epidermal growth factor (EGF)-like repeats and a shorter intracellular domain than other mouse Notch homologues. Comparison of the coding potential of the int-3 gene to that of Notch4 suggests that loss of the extracellular domain of Notch4 leads to constitutive activation of this murine Notch protein. In situ hybridization revealed that Notch4 transcripts are primarily restricted to endothelial cells in embryonic and adult life. Truncated Notch4 transcripts were detected in post-meiotic male germ cells. The distinct Notch4 protein features and its restricted expression pattern suggests a specific role for Notch4 during development of vertebrate endothelium.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8681805     DOI: 10.1242/dev.122.7.2251

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  163 in total

1.  Notch signaling is essential for vascular morphogenesis in mice.

Authors:  L T Krebs; Y Xue; C R Norton; J R Shutter; M Maguire; J P Sundberg; D Gallahan; V Closson; J Kitajewski; R Callahan; G H Smith; K L Stark; T Gridley
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

2.  Dll4, a novel Notch ligand expressed in arterial endothelium.

Authors:  J R Shutter; S Scully; W Fan; W G Richards; J Kitajewski; G A Deblandre; C R Kintner; K L Stark
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

3.  SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation.

Authors:  G Wu; S Lyapina; I Das; J Li; M Gurney; A Pauley; I Chui; R J Deshaies; J Kitajewski
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

4.  Members of the Jagged/Notch gene families are expressed in injured arteries and regulate cell phenotype via alterations in cell matrix and cell-cell interaction.

Authors:  V Lindner; C Booth; I Prudovsky; D Small; T Maciag; L Liaw
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

5.  Notch signaling during vascular development.

Authors:  T Gridley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

6.  Notch signalling via RBP-J promotes myeloid differentiation.

Authors:  T Schroeder; U Just
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

7.  Members of the HRT family of basic helix-loop-helix proteins act as transcriptional repressors downstream of Notch signaling.

Authors:  O Nakagawa; D G McFadden; M Nakagawa; H Yanagisawa; T Hu; D Srivastava; E N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 8.  The notch pathway: modulation of cell fate decisions in hematopoiesis.

Authors:  K Ohishi; B Varnum-Finney; I D Bernstein
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

9.  Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: role of p21Cip1 repression.

Authors:  Michela Noseda; Linda Chang; Graeme McLean; Jonathan E Grim; Bruce E Clurman; Laura L Smith; Aly Karsan
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

10.  Tumor-infiltrating myeloid cells activate Dll4/Notch/TGF-β signaling to drive malignant progression.

Authors:  Hidetaka Ohnuki; Kan Jiang; Dunrui Wang; Ombretta Salvucci; Hyeongil Kwak; David Sánchez-Martín; Dragan Maric; Giovanna Tosato
Journal:  Cancer Res       Date:  2014-02-11       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.